FR2903984B1 - Derives d'imidazolones substitues, preparation et utilisations - Google Patents
Derives d'imidazolones substitues, preparation et utilisationsInfo
- Publication number
- FR2903984B1 FR2903984B1 FR0606752A FR0606752A FR2903984B1 FR 2903984 B1 FR2903984 B1 FR 2903984B1 FR 0606752 A FR0606752 A FR 0606752A FR 0606752 A FR0606752 A FR 0606752A FR 2903984 B1 FR2903984 B1 FR 2903984B1
- Authority
- FR
- France
- Prior art keywords
- preparation
- imidazolone derivatives
- substituted
- substituted imidazolone
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606752A FR2903984B1 (fr) | 2006-07-24 | 2006-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
KR1020097003832A KR20090038469A (ko) | 2006-07-24 | 2007-07-24 | 치환된 이미다졸론 유도체, 그 제조 및 용도 |
AU2007279135A AU2007279135A1 (en) | 2006-07-24 | 2007-07-24 | Substituted imidazolone derivatives, preparation and uses |
PCT/FR2007/051716 WO2008012470A2 (fr) | 2006-07-24 | 2007-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
EP07823633A EP2049107A2 (fr) | 2006-07-24 | 2007-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
NZ575011A NZ575011A (en) | 2006-07-24 | 2007-07-24 | Substituted imidazolone derivatives, preparation and uses |
CNA2007800352070A CN101522192A (zh) | 2006-07-24 | 2007-07-24 | 取代的咪唑啉酮衍生物、制备和用途 |
CA002658625A CA2658625A1 (fr) | 2006-07-24 | 2007-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
US12/309,642 US20100004159A1 (en) | 2006-07-24 | 2007-07-24 | Substituted imidazolone derivatives, preparations and uses |
EA200900211A EA200900211A1 (ru) | 2006-07-24 | 2007-07-24 | Замещенные производные имидазолона, их получение и применение |
JP2009521318A JP2009544675A (ja) | 2006-07-24 | 2007-07-24 | 置換されたイミダゾロン誘導体、製造方法及び使用 |
MX2009000900A MX2009000900A (es) | 2006-07-24 | 2007-07-24 | Derivados de imidazolonas sustituidas, preparacion y usos. |
BRPI0715326-0A BRPI0715326A2 (pt) | 2006-07-24 | 2007-07-24 | compostos derivados de imidazolonas polissubstituÍdas, composiÇço farmacÊutica e, uso de pelo menos um composto |
IL196671A IL196671A0 (en) | 2006-07-24 | 2009-01-22 | Substituted imidazolone derivatives, preparation and uses |
NO20090348A NO20090348L (no) | 2006-07-24 | 2009-01-22 | Substituerte imidazolonderivater, sammensetninger og anvendelser av samme, samt fremgangsmater for fremstilling av samme |
ZA200901268A ZA200901268B (en) | 2006-07-24 | 2009-02-23 | Substituted imidazolone derivatives, preparation and uses |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0606752A FR2903984B1 (fr) | 2006-07-24 | 2006-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2903984A1 FR2903984A1 (fr) | 2008-01-25 |
FR2903984B1 true FR2903984B1 (fr) | 2008-10-03 |
Family
ID=37843186
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0606752A Expired - Fee Related FR2903984B1 (fr) | 2006-07-24 | 2006-07-24 | Derives d'imidazolones substitues, preparation et utilisations |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100004159A1 (fr) |
EP (1) | EP2049107A2 (fr) |
JP (1) | JP2009544675A (fr) |
KR (1) | KR20090038469A (fr) |
CN (1) | CN101522192A (fr) |
AU (1) | AU2007279135A1 (fr) |
BR (1) | BRPI0715326A2 (fr) |
CA (1) | CA2658625A1 (fr) |
EA (1) | EA200900211A1 (fr) |
FR (1) | FR2903984B1 (fr) |
IL (1) | IL196671A0 (fr) |
MX (1) | MX2009000900A (fr) |
NO (1) | NO20090348L (fr) |
NZ (1) | NZ575011A (fr) |
WO (1) | WO2008012470A2 (fr) |
ZA (1) | ZA200901268B (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2025674A1 (fr) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament |
WO2011107494A1 (fr) | 2010-03-03 | 2011-09-09 | Sanofi | Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation |
AU2011232657A1 (en) * | 2010-03-26 | 2012-09-27 | Merck Sharp & Dohme Corp. | Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
US8933024B2 (en) | 2010-06-18 | 2015-01-13 | Sanofi | Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
US8633231B2 (en) | 2010-07-13 | 2014-01-21 | Merck Sharp & Dohme Corp. | Substituted imidazolones, compositions containing such compounds and methods of use |
WO2013037390A1 (fr) | 2011-09-12 | 2013-03-21 | Sanofi | Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
WO2013045413A1 (fr) | 2011-09-27 | 2013-04-04 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase |
MX2015016543A (es) * | 2013-06-27 | 2017-07-27 | Lg Chemical Ltd | Derivados de biarilo como agonistas de gpr120. |
CA2934257C (fr) | 2013-12-17 | 2022-06-07 | Janssen Pharmaceutica Nv | Derive d'imidazoline-5-one utile en tant qu'inhibiteur de fas pour le traitement du cancer |
CN105439946B (zh) * | 2014-08-13 | 2018-02-02 | 益方生物科技(上海)有限公司 | 羧酸化合物及其制备方法和用途 |
CN104177298B (zh) * | 2014-09-18 | 2018-10-02 | 湘潭大学 | 4,4-二取代-4,5-二氢-1h–咪唑-5-酮、衍生物及其合成方法 |
AU2016296205B2 (en) | 2015-07-17 | 2021-11-11 | Centre Hospitalier Sainte Anne Paris | 5-hydroxytryptamine 1B receptor-stimulating agent for use as a promoter of satellite cells self-renewal and/or differentiation |
WO2017043092A1 (fr) * | 2015-09-11 | 2017-03-16 | Raqualia Pharma Inc. | Dérivés d'imidazolinone utilisés en tant qu'antagonistes de trpm8 |
EP3436434B1 (fr) | 2016-03-31 | 2020-07-08 | Oncternal Therapeutics, Inc. | Analogues d'indoline et leurs utilisations |
KR20190038840A (ko) | 2016-07-15 | 2019-04-09 | 앵스띠뛰 파스퇴르 | 피부 및/또는 모발 복구를 위한 5-하이드록시트립타민 1b 수용체-자극제 |
CN113121394B (zh) * | 2019-12-30 | 2022-11-08 | 中国药科大学 | 一种苯氧乙酸类衍生物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050044606A (ko) * | 2001-11-30 | 2005-05-12 | 일라이 릴리 앤드 캄파니 | 퍼옥시솜 증식제에 의해 활성화된 수용체 아고니스트 |
US7232828B2 (en) * | 2002-08-10 | 2007-06-19 | Bethesda Pharmaceuticals, Inc. | PPAR Ligands that do not cause fluid retention, edema or congestive heart failure |
US20050020654A1 (en) * | 2003-03-15 | 2005-01-27 | Pershadsingh Harrihar A. | Novel PPAR agonists, pharmaceutical compositions and uses thereof |
-
2006
- 2006-07-24 FR FR0606752A patent/FR2903984B1/fr not_active Expired - Fee Related
-
2007
- 2007-07-24 US US12/309,642 patent/US20100004159A1/en not_active Abandoned
- 2007-07-24 MX MX2009000900A patent/MX2009000900A/es active IP Right Grant
- 2007-07-24 CA CA002658625A patent/CA2658625A1/fr not_active Abandoned
- 2007-07-24 BR BRPI0715326-0A patent/BRPI0715326A2/pt not_active IP Right Cessation
- 2007-07-24 WO PCT/FR2007/051716 patent/WO2008012470A2/fr active Application Filing
- 2007-07-24 EA EA200900211A patent/EA200900211A1/ru unknown
- 2007-07-24 NZ NZ575011A patent/NZ575011A/en not_active IP Right Cessation
- 2007-07-24 JP JP2009521318A patent/JP2009544675A/ja active Pending
- 2007-07-24 AU AU2007279135A patent/AU2007279135A1/en not_active Abandoned
- 2007-07-24 EP EP07823633A patent/EP2049107A2/fr not_active Withdrawn
- 2007-07-24 KR KR1020097003832A patent/KR20090038469A/ko not_active Application Discontinuation
- 2007-07-24 CN CNA2007800352070A patent/CN101522192A/zh active Pending
-
2009
- 2009-01-22 IL IL196671A patent/IL196671A0/en unknown
- 2009-01-22 NO NO20090348A patent/NO20090348L/no not_active Application Discontinuation
- 2009-02-23 ZA ZA200901268A patent/ZA200901268B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CA2658625A1 (fr) | 2008-01-31 |
ZA200901268B (en) | 2010-04-28 |
NZ575011A (en) | 2011-12-22 |
CN101522192A (zh) | 2009-09-02 |
NO20090348L (no) | 2009-04-24 |
WO2008012470A2 (fr) | 2008-01-31 |
IL196671A0 (en) | 2009-11-18 |
US20100004159A1 (en) | 2010-01-07 |
MX2009000900A (es) | 2009-06-18 |
KR20090038469A (ko) | 2009-04-20 |
BRPI0715326A2 (pt) | 2013-08-13 |
EA200900211A1 (ru) | 2009-06-30 |
EP2049107A2 (fr) | 2009-04-22 |
WO2008012470A3 (fr) | 2008-03-20 |
FR2903984A1 (fr) | 2008-01-25 |
JP2009544675A (ja) | 2009-12-17 |
AU2007279135A1 (en) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2903984B1 (fr) | Derives d'imidazolones substitues, preparation et utilisations | |
ATE543808T1 (de) | 5,6-ring-annelierte indolderivate und ihre verwendung | |
ATE505467T1 (de) | 2-aza-bicycloä3.1.0ühexanderivate als orexin- rezeptorantagonisten | |
ATE481383T1 (de) | 3-aza-bicycloä3.1.0ühexanderivate | |
BRPI0811718A2 (pt) | Derivados de 3,3-espiroindolinona | |
EP2124551A4 (fr) | 1,3-dioxanes substitués et leurs utilisations | |
ATE471938T1 (de) | Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten | |
FR2919608B1 (fr) | Derives d'imidazolones,procede de preparation et applications biologiques | |
ATE467633T1 (de) | 2-aryl-6-phenylimidazoä1,2-aüpyridin-derivate, ihre herstellung und therapeutische verwendung | |
CR10733A (es) | Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof | |
DK1824856T3 (da) | 2,4 (4,6)-pyrimidinderivater | |
FR2884516B1 (fr) | Antagonistes npy, preparation et utilisations | |
NL1031473A1 (nl) | Cyclopentapyridine- en tetrahydrochinolinederivaten. | |
DE602008005634D1 (de) | 1,1,1-trifluor-2-hydroxy-3-phenylpropan-derivate | |
ATE494290T1 (de) | Substituierte 2,5-dihydro-3h-pyrazol-ä4,3-cü- pyridazin-3-on-derivate, ihre herstellung und ihre verwendung als cannibinoid-cb1- rezeptorliganden | |
ATE507223T1 (de) | N-cycloalkyl-carboxamid-, thiocarboxamid- und n- substitutierte carboximidamid-derivate als fungizide | |
FR2898894B1 (fr) | Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations | |
BRPI0813341A2 (pt) | " uso de compostos, composições curáveis, e, uso de composições curáveis ". | |
DE602007010118D1 (de) | 2-substituierte 4-benzylphthalazinonderivate als histamin-h1- und h3-antagonisten | |
BRPI0919248A2 (pt) | derivados de 3-amino-indazol ou 3-amino-4,5,6,7-tetraidroindazol | |
ATE555785T1 (de) | Triazolderivate als smo-antagonisten | |
DK1626964T3 (da) | Nye benzimidazolderivater | |
IL187426A0 (en) | Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists | |
ATE472549T1 (de) | Octahydropyrroloä3,4-cüpyrrolderivate und ihre verwendung als antivirale mittel | |
ATE454377T1 (de) | 2-phenyl-6-aminocarbonylpyrimidinderivate und ihre verwendung als antagonisten am p2y12- rezeptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20100331 |